{"id":"W2055183928","doi":"10.1016/j.ygyno.2011.11.042","title":"A phase II study single agent of aflibercept (VEGF Trap) in patients with recurrent or metastatic gynecologic carcinosarcomas and uterine leiomyosarcoma. A trial of the Princess Margaret Hospital, Chicago and California Cancer Phase II Consortia","year":2011,"lang":"en","type":"article","venue":"Gynecologic Oncology","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; Juravinski Cancer Centre; Princess Margaret Cancer Centre","funders":"National Cancer Institute; U.S. Public Health Service","keywords":"Medicine; Aflibercept; Leiomyosarcoma; Carcinosarcoma; Sarcoma; Internal medicine; Uterine sarcoma; Surgery; Oncology; Cancer; Chemotherapy; Bevacizumab; Gynecology; Pathology; Carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000336405,0.0003896319,0.001334389,0.000188593,0.0001533835,0.000005996963,0.0001993479,0.0001409786,0.0005500186],"category_scores_gemma":[0.0001868466,0.0002114269,0.00008947327,0.0003414187,0.0005966413,0.00007115258,0.0004458994,0.0002535637,6.402611e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002378249,"about_ca_system_score_gemma":0.0003238259,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002880384,"about_ca_topic_score_gemma":0.002285593,"domain_scores_codex":[0.997376,0.0004000528,0.0009052944,0.0005874476,0.0002781209,0.0004530893],"domain_scores_gemma":[0.9983391,0.0002387498,0.0006861312,0.0004152282,0.0001433112,0.000177486],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06223392,0.1657633,0.6945362,0.0002110925,0.000916831,0.0004718382,0.005496481,5.705962e-7,0.0002080595,0.00001654706,0.00005537746,0.07008975],"study_design_scores_gemma":[0.1969369,0.2852857,0.5153033,0.00004659478,0.0007656606,0.00001893935,0.0004678813,0.00001647419,0.0001876442,0.00002987761,0.0007673305,0.0001737012],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933601,0.0001939779,0.000002957438,0.0003239669,0.000343385,0.005346528,0.0002623561,0.0000230391,0.0001437138],"genre_scores_gemma":[0.9983338,0.00009490068,0.0007066791,0.0001056175,0.00001738964,0.0006160092,0.00003073172,0.00002359448,0.00007126742],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1792329,"threshold_uncertainty_score":0.8621738,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05281627150246025,"score_gpt":0.3383873733957119,"score_spread":0.2855711018932516,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}